Section Arrow
Quote
NAOV.NASDAQ
- NanoVibronix Inc
Quotes are at least 15-min delayed:2025/06/28 01:46 EDT
Last
 1.17
+0.3009 (+34.62%)
Day High 
1.32 
Prev. Close
0.8691 
1-M High
1.66 
Volume 
37.12M 
Bid
1.11
Ask
1.12
Day Low
1.07 
Open
1.09 
1-M Low
0.6669 
Market Cap 
2.25M 
Currency USD 
P/E -- 
%Yield 10 
10-SMA 0.95 
20-SMA 0.99 
50-SMA 2.69 
52-W High 16.25 
52-W Low 0.6669 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-15.33/-0.43
Enterprise Value
2.31M
Balance Sheet
Book Value Per Share
13.80
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
2.56M
Operating Revenue Per Share
0.25
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
AMIXAutonomix Medical Inc2.01+0.76+60.80%-- 
NAOVNanoVibronix Inc1.17+0.3009+34.62%-- 
BFLYButterfly Network1.96-0.06-2.97%-- 
BBLGBone Biologics Corp4.58+0.42+10.10%0.08PE
BSXBoston Scientific Corp106.53+1.95+1.86%76.05PE
Quotes are at least 15-min delayed：2025/06/28 01:46 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients, through distributor agreements.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.